Ebola and West Africa: Three Things to Know
Videos

Ebola and West Africa: Three Things to Know

September 29, 2014 12:28 pm (EST)

Ebola and West Africa: Three Things to Know
Explainer Video

West African governments and aid agencies face a number of challenges in attempting to contain the Ebola epidemic, which health officials say threatens to infect more than one million people by early next year. Containing the outbreak will require a massive international response similar to that coordinated after the 2004 South Asia tsunami. CFR’s John Campbell offers three things to know about Ebola and West Africa:

- Popular Suspicions: Many residents of Guinea, Sierra Leone, and Liberia—the epicenters of Ebola—are distrustful of their leaders, and some view the disease as witchcraft, says Campbell. As a result, many Ebola victims and their families have resisted government-led efforts to control the outbreak.

More From Our Experts

- Communication Issues: Governments and aid agencies face major communication problems in West Africa, which is a multilingual region with low literacy levels, explains Campbell. In addition, efforts to educate the population about Ebola were developed late.

- A Global Problem: Governments in the region battling the disease need resources that only foreign partners can provide. "International efforts similar to the global response to the South Asian tsunami could help stop the spread of Ebola in West Africa," says Campbell.

More From Our Experts

Top Stories on CFR

Israeli-Palestinian Conflict

An impending Israeli ground invasion of Rafah could threaten more than a million civilians seeking refuge in the city and further restrict humanitarian aid into the Gaza Strip.

Maldives

Once a close Indian partner, the Maldives is now aligning more with China. Is the island nation becoming a flash point in the China-India relationship? 

Public Health Threats and Pandemics

A global surge in avian flu outbreaks in birds and some mammals is worrying poultry farmers, scientists, and health experts. The trend is provoking questions about the future of the disease and global public health.